Expression of biologically active human vascular endothelial growth factor in yeast

D. Mohanraj, T. Olson, Sundaram Ramakrishnan

Research output: Contribution to journalArticle

26 Scopus citations

Abstract

Vascular endothelial growth factor (VEGF) is a glycoprotein consisting of two identical polypeptide chains linked by a disulfide bond. The unique biological activities of VEGF include its potent mitogenic and permeability inducing properties specific for the vascular endothelium. VEGF is implicated in tumor angiogenesis, wound healing, and the stimulation of collateral vessel formation at the site of arterial occlusion. Therefore, in order to produce large quantities of biologically active VEGF, a splice variant (VEGF165) was cloned and expressed in a yeast expression system. The coding region of VEGF165 was isolated from U937 cells by RT-PCR, sequenced and then cloned into the yeast expression vector pHILS1. VEGF165 was secreted into the medium as a dimer. Recombinant VEGF reacted to antibodies raised against the N-terminal and C-terminal synthetic polypeptides of human VEGF. As much as 35-40 mg/L of purified VEGF could be obtained from the yeast expression system. The recombinant protein was biologically active in inducing vascular endothelial cell proliferation in vitro and permeability changes in vivo.

Original languageEnglish (US)
Pages (from-to)17-27
Number of pages11
JournalGrowth Factors
Volume12
Issue number1
DOIs
StatePublished - Jan 1 1995
Externally publishedYes

    Fingerprint

Keywords

  • Protein expression
  • Recombinant human VEGF
  • Vascular endothelium

ASJC Scopus subject areas

  • Endocrinology
  • Clinical Biochemistry
  • Cell Biology

Cite this